Entero Healthcare Solutions experienced a subdued debut in the stock market, with its shares opening at a discount. On the NSE, the stock commenced trading at ₹1,228.70 per share, marking a 2.33% drop from its issue price of ₹1,258. Similarly, on the BSE, the shares were listed at ₹1,245 each, 1.03% lower than the issue price, reflecting a cautious start for the company in the public market.
The public issue worth Rs 1,600 crore, open for bids between February 9 and 13, witnessed a subscription of 1.53 times. While qualified institutional buyers subscribed to 2.28 times their share quota, retail investors reached 1.33 times. However, non-institutional investors showed limited interest, purchasing just 22 percent of their reserved share allocation in the offer.
Entero Healthcare Solutions, a leading healthcare product distributor in India, achieved INR 2,522.065 crores in operating income by FY2022, rapidly growing to INR 2500 crores in just four years. They connect manufacturers with pharmacies, hospitals, and clinics, distributing over 64,500 SKUs from 1,900+ manufacturers through a network of 73 warehouses, serving 81,400 retail and 3,400 hospital customers.
Entero Healthcare Solutions Ltd plans to use its IPO funds for debt repayment, enhancing working capital, and strategic acquisitions to bolster market presence and product range. Additionally, funds will support general corporate needs, including marketing, brand building, and meeting business contingencies.
